Episode 267: Aidan Kehoe (replay)

This week, we interviewed Chuck Brynelsen. Chuck is currently the Chair of the Board of Directors at Envoy Medical; he serves on the board of Alebra Technologies and is a Venture Partner at SpringRock Ventures. Previously, Chuck served as a Senior Vice President of Abbot Vascular; Chuck Brynelsen led an organization focused on reducing cardiovascular disease's global impact. Chuck was previously the Global President of Early Technologies for Medtronic and President of Early Technologies for Covidien. Chuck has also spent seven years as CEO of Intrapace, a start-up medical device company treating obesity. Before Intrapace, Check spent 24 years at Medtronic in various regional, business unit, and corporate leadership roles. The company went from a $250 million pacemaker company to a diversified medical technology enterprise with over $10 billion in revenues.

This week, we interviewed John Hironimus. John is the CEO of Origami Surgical, an accomplished medical device executive with a track record of successfully commercializing novel medical devices. He has focused on scaling new technologies and applications to benefit patients, clinicians, and providers. His 25 years of experience span numerous areas of healthcare. An entrepreneur at heart, his passion is building world-class teams who relentlessly focus on improving patient care.   John began his career with United States Surgical Corporation, helping surgeons provide advanced procedures to their patients. He then built the domestic and international commercial team for Salient Surgical Technologies, culminating in a successful acquisition by Medtronic in 2011. Under his leadership, the business grew from $40M in revenue to over $350M. John has most recently led commercial teams at Outset Medical and Dilon Technologies.    John graduated from Indiana University, earning a Public Financial Management degree.

This week, we revisit our interview with Keith Grossman. He currently serves as Chairman of Nevro Corp. (NVRO), Vice-Chairman of Alcon, Inc. (ALC), and Lead Director of Outset Medical, Inc. (OM). Previously, Keith was the CEO and President of Nevro. Keith has over 40 years of experience in the medical device field. He served most recently, and for the second time, as the President, Chief Executive Officer, and director of Thoratec Corporation, leading up to its 2015 sale to St. Jude Medical.   Before Thoratec, he served as President, Chief Executive Officer, and director of Conceptus, a women’s health medical device company, leading up to its sale to Bayer Healthcare. Before Conceptus, Keith served as managing director of TPG (Texas Pacific Group), a private equity firm, and was a member of its healthcare investment team. Prior to TPG, Keith served as Thoratec’s President, Chief Executive Officer, and director for the first ten years of its growth as a commercial company.  Keith was chronicled in the book “Executive Intelligence: What All Great Leaders Have”, was named among the “Business Leaders to Watch” and the “40 Under 40” lists in the Bay Area and was awarded the Lifetime Achievement Award by his Medical Device CEO peers. Keith received a B.S. in life sciences from The Ohio State University and an M.B.A. from Pepperdine University.

This week, we welcome back Chuck Bolton. Chuck is a six-time bestselling author and executive coach to CEO's. As founder of The Bolton Group LLC, he provides leadership coaching and consulting in the medtech and healthtech sectors. We discuss Chuck's new book The CEO's AI Playbook and how a leader can lead with vision and purpose in the age of AI.He addresses how to build an AI-ready culture that puts humans first. Through The Reinvention Solution LLC, Chuck delivers Gen AI education and consulting to B2B clients. His acclaimed Gen Ai for CEOs and Gen Ai for Boards crash courses are essential learning for senior executives and board members seeking to create value through AI.

This week, we revisit our interview with Kara Goldin, the Founder of Hint, Inc., best known for its award-winning Hint® water, the leading unsweetened flavored water, and the author of Undaunted.   Kara has been named among Fortune's Most Powerful Women Entrepreneurs and Forbes' 40 Women to Watch Over 40. She is an active speaker & writer and hosts the podcast The Kara Goldin Show, where she interviews founders, entrepreneurs, and other disruptors across various industries. She lives in the Bay Area.   Follow Kara on all social handles @KaraGoldin  

This week we revisit our interview with Michael Bungay Stanier. Michael is the author of six books and is best known for The Coaching Habit, the best-selling coaching book of the century with over a million copies sold and already recognized as a classic. We discuss Michael’s brand-new book, How To Begin. Michael was a Rhodes Scholar and plays the ukulele badly. He’s Australian and lives in Toronto, Canada. Learn more at www.MBS.works.

This week, we revisit our interview with Aidan Kehoe. Aidan is currently the Founder and Managing Partner of Nadia Partners. Previously, he was the founder and CEO of SKOUT Cybersecurity (Acquired by Barracuda Networks). Mr. Kehoe was actively involved in all aspects of the firm's development and expansion since its launch in 2014. Prior to Skout, Aidan founded several other enterprises, including Oxford Global, a global risk management company, which was acquired by Willis Towers Watson in 2013. He also has many years of experience working in an investment capacity with an institutionally sized private family office investing in both private and public investment vehicles. Aidan is the chairman of the U.S. Leaders Council of Cordaid, serving the most vulnerable people in the most fragile places in the world. He also serves on the board of Autism Speaks. Originally from Ireland, he has served as a board member to both public and private equity-backed companies throughout the United States, Canada and Europe. He has extensive experience in leading and building teams who tackle the hardest problems.

This week, we revisit our interview with Dr. Jeff Holmes. Jeff has more than 24 years of experience in executive-level positions, including 12+ years in founder, executive, and lead roles. Jeff provides senior executive coaching, CEO advising, and C-suite consulting. A dedicated coach for over 30 years, he has worked with top leaders during times of crisis and helped numerous young high potentials move from graduation to placement in high-level leadership roles across the US. 

This week, we revisit our interview with Emily Jordan. Emily is a dynamic force in the world of marketing. She holds a remarkable track record across various sectors such as tech, sports/fitness, healthcare, retail and has led teams at global heavyweights like Nike and Google as well as nimble, high-growth startups like Tubi and Willow. Most recently, she was steering the ship as the VP of Marketing at Willow Innovations spearheading consumer awareness, brand strategy and performance marketing. She’s an expert architect of brand campaigns, product launches, and digital initiatives and enjoys nothing more than masterfully constructing high-caliber marketing teams under a culture infused with innovation and collaboration. She has won a number of AdWeek and AdAge awards for her provocative brand campaigns and a Cannes Lion for her work on Google’s first popup store and retail strategy.  Emily lives in Oakland California with her husband, Dan and daughter, Jovie. She credits much of her success to having a supportive partner, a helpful support system and her midwestern work ethic.

This week, we revisit our interview with Nick Damiano. Nick is a serial entrepreneur focused on solving unmet needs to improve patient care. He is currently CEO & Founder of Andromeda Surgical, which is developing autonomous robots for safer, better, more efficient surgery. Before that, he was CEO & Co-Founder of Zenflow, where he co-invented a novel implant for BPH (enlarged prostate) and led the product from inception through multiple clinical trials to commercial readiness, raising over $60M in funding. He was also CTO & co-founder at Nurep, later re-branded as Avail MedSystems. He was the key architect of the company's remote surgical support product for operating rooms that is now used in hundreds of medical facilities. Nick earned his M.S. and B.S. with Distinction in Management Science & Engineering from Stanford University and was an Innovation Fellow at Stanford Byers Center for Biodesign. He was the first medtech founder to be funded by Y Combinator twice and actively advises startups through StartX, UCSF Rosenman Institute, and Nucleate Bio. He also dabbles on the investor side as a Venture Partner at Pioneer Fund.